Zai Lab Ltd logo

Zai Lab Ltd - ADR Repr 1 Shs

NAS:ZLAB (China)   ADR Repr 1 Shs
$ 18.57 +0.57 (+3.17%) 03:54 PM EST
At Loss
P/B:
2.37
Volume:
524.25K
Avg Vol (2M):
658.43K
Trade In:
Volume:
524.25K
At Loss
Avg Vol (2M):
658.43K

Business Description

Description
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
Name Current Vs Industry Vs History
Cash-To-Debt 10.27
Equity-to-Asset 0.77
Debt-to-Equity 0.08
Debt-to-EBITDA -0.18
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.5
Distress
Grey
Safe
Beneish M-Score -2.55
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 21.79
9-Day RSI 35.95
14-Day RSI 43.31
6-1 Month Momentum % -27.74
12-1 Month Momentum % -22.99

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.63
Quick Ratio 4.43
Cash Ratio 3.39
Days Inventory 136.19
Days Sales Outstanding 63.16
Days Payable 263.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.5
Shareholder Yield % -0.47

Financials (Next Earnings Date:2024-08-07 Est.)

ZLAB's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ZLAB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Zai Lab Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 291.071
EPS (TTM) ($) -3.5
Beta 0.97
Volatility % 41.52
14-Day RSI 43.31
14-Day ATR ($) 0.945768
20-Day SMA ($) 18.8325
12-1 Month Momentum % -22.99
52-Week Range ($) 13.48 - 32.6
Shares Outstanding (Mil) 98.72

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Zai Lab Ltd Filings

Filing Date Document Date Form
No Filing Data

Zai Lab Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Zai Lab Ltd Frequently Asked Questions

What is Zai Lab Ltd(ZLAB)'s stock price today?
The current price of ZLAB is $18.57. The 52 week high of ZLAB is $32.60 and 52 week low is $13.48.
When is next earnings date of Zai Lab Ltd(ZLAB)?
The next earnings date of Zai Lab Ltd(ZLAB) is 2024-08-07 Est..
Does Zai Lab Ltd(ZLAB) pay dividends? If so, how much?
Zai Lab Ltd(ZLAB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1